System-Level Advocacy That Affects Adults

As an adult living with short bowel syndrome, much of your day-to-day energy goes toward managing nutrition, fluids, medications, and complications. Yet the systems that shape your care — research funding, clinical guidelines, insurance coverage, drug and device access, and public awareness — are often influenced by people and organizations far removed from your lived experience.

System-level advocacy is the work of changing those larger structures so that adults with SBS are no longer an afterthought.

Adult SBS remains under-studied relative to its impact. Many clinical trials and research agendas still prioritize pediatric populations or broader gastrointestinal diseases. Adults with SBS can help shift that balance.

Participate in surveys, focus groups, or advisory boards through Oley, SBSF, and intestinal failure centers. Real-world data on adult outcomes, quality of life, and unmet needs helps shape research priorities.

Public comment periods and patient-representative seats on guideline committees are opportunities to insist that adult-specific issues — employment, aging with SBS, fertility, long-term catheter complications, and rehabilitation — are addressed.

Patient testimony before the FDA, participation in patient-focused drug development meetings, and collaboration with industry advisory boards help ensure that endpoints that matter to adults — reduced infusion days, fewer hospitalizations, better quality of life — are prioritized.

Coverage decisions for adults with SBS are frequently more restrictive than those for children. Prior authorizations, step therapy, quantity limits, and denials for “not medically necessary” are common barriers.

State Medicaid programs, Medicare coverage decisions, and state insurance mandates all affect access. Joining or supporting campaigns led by rare-disease or home-infusion coalitions multiplies individual effort.

Pharmaceutical and device companies developing SBS therapies often create patient advisory boards. Serving on these groups allows you to shape trial design, educational materials, and post-marketing support. Intestinal failure centers and professional societies increasingly include patient representatives on education committees, conference planning, and quality-improvement projects.

Legislative and regulatory staff rarely encounter SBS. Concise, personal stories paired with specific policy asks — coverage of growth factors without excessive barriers, support for intestinal rehabilitation centers, research funding — are effective. Consistency, preparation, and a focus on solutions strengthen your voice.

Public and professional awareness of adult SBS remains limited. Many people still associate the condition primarily with infants and young children. Targeted awareness work helps change that.

System-level advocacy does not require becoming a full-time activist. Many adults contribute through occasional testimony, survey participation, sharing their story when asked, or supporting organizations that do the sustained policy work.

The cumulative effect is that adults with SBS become visible in the rooms where decisions about research, coverage, guidelines, and public understanding are made. Your experience is not only personal — it is data, evidence, and expertise that the systems affecting adult SBS still need.